SCHEMBL24898060

SCHEMBL24898060

CN(C)c1cc(C(F)(F)F)cc(F)c1N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.35
▸ NOS3 P29474 2/20 0.35
▸ NOS1 P29475 2/20 0.35
▸ NOS2 P35228 2/20 0.35
▸ GPBAR1 Q8TDU6 6/20 0.33
▸ GAA P10253 3/20 0.33
▸ PDE2A O00408 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ KMT2A Q03164 1/20 0.32
▸ MPL P40238 1/20 0.32
▸ APAF1 O14727 1/20 0.32
▸ TDP2 O95551 1/20 0.32
▸ NSD2 O96028 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ GALK1 P51570 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ CASP6 P55212 1/20 0.32
▸ SAE1 Q9UBE0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3323506 0.79 TSHR (0.41) IDO1NOS3NOS2PDE2AALDH1A1
SCHEMBL2669995 0.75 POLB (0.43) IDO1NOS3NOS2PDE2AALDH1A1
SCHEMBL30214898 0.75 POLB (0.43) IDO1NOS3NOS2PDE2AALDH1A1
SCHEMBL4468976 0.75 GAA (0.36) GAAALDH1A1KMT2AAPAF1TDP2
SCHEMBL442808 0.73 ALDH1A1 (0.50) IDO1NOS3NOS2GAAPDE2A
SCHEMBL9234432 0.72 PDE2A (0.42) IDO1GPBAR1GAAPDE2AMPL
SCHEMBL11695402 0.71 KIF11 (0.38) IDO1NOS3NOS2GAAPDE2A
SCHEMBL10185017 0.71 ALDH1A1 (0.42) NOS3NOS2GAAALDH1A1KMT2A
SCHEMBL21603365 0.69 CA1 (0.47) IDO1NOS3NOS2GAAPDE2A
SCHEMBL29778868 0.69 CA1 (0.47) IDO1NOS3NOS2GAAPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023288242-A1 PI3Kα INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-01-19 — — WO disclosed
Send feedback